5 ML neostigmine methylsulfate 1 MG/ML Prefilled Syringe
- RxCUI
- 1668225
- RxNorm name
- 5 ML neostigmine methylsulfate 1 MG/ML Prefilled Syringe
- Display name
- 5 ML neostigmine methylsulfate 1 MG/ML Prefilled Syringe
- Full name
- 5 ML neostigmine methylsulfate 1 MG/ML Prefilled Syringe
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:22
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bloxiverz | NEOSTIGMINE METHYLSULFATE | Exela Pharma Sciences, LLC | d2f55643-2b0d-4ef9-a9d8-b7138b314372 | 2023-12-31 | Warnings, Adverse reactions | 1668225 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d2f55643-2b0d-4ef9-a9d8-b7138b314372 | 5 ML neostigmine methylsulfate 1 MG/ML Prefilled Syringe | SCD | 18 | These highlights do not include all the information needed to use BLOXIVERZ ® safely and effectively. See full prescribing information for BLOXIVERZ. BLOXIVERZ (Neostigmine Methylsulfate Injection), for intravenous use Initial U.S. Approval: 1939 | 20231231 |
| d2f55643-2b0d-4ef9-a9d8-b7138b314372 | neostigmine methylsulfate 5 MG in 5 ML Prefilled Syringe | PSN | 18 | These highlights do not include all the information needed to use BLOXIVERZ ® safely and effectively. See full prescribing information for BLOXIVERZ. BLOXIVERZ (Neostigmine Methylsulfate Injection), for intravenous use Initial U.S. Approval: 1939 | 20231231 |
| d2f55643-2b0d-4ef9-a9d8-b7138b314372 | neostigmine methylsulfate 5 MG per 5 ML Prefilled Syringe | SY | 18 | These highlights do not include all the information needed to use BLOXIVERZ ® safely and effectively. See full prescribing information for BLOXIVERZ. BLOXIVERZ (Neostigmine Methylsulfate Injection), for intravenous use Initial U.S. Approval: 1939 | 20231231 |